previously treated, advanced
Showing 1 - 1 of 1
Previously Treated, Advanced, Malignancies Trial (TAB006, Toripalimab)
Withdrawn
- Previously Treated, Advanced
- Malignancies
- (no location specified)
May 24, 2022